ArticleJournal of personalized medicine2025

Selective IgM Hypogammaglobulinemia and Multiple Sclerosis Treated with Natalizumab and Ofatumumab: A Case Report.

Francesco Crescenzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.